Evidence map›Paper›PMID 25131209›Full record

ArticleCell reports2014

Kcnn4 is a regulator of macrophage multinucleation in bone homeostasis and inflammatory disease.

Heeseog Kang, Audrey Kerloc'h, Maxime Rotival, Xiaoqing Xu, Qing Zhang, Zelpha D'Souza, Michael Kim, Jodi Carlson Scholz, Jeong-Hun Ko, Prashant K Srivastava and 18 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 62 citations in OpenAlex.

  1. Interleukin-9 Facilitates Osteoclastogenesis in Rheumatoid Arthritis.International journal of molecular sciences · 2021
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Frontiers in cellular and infection microbiology · 2022
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 7 institutions in 2 countries.

Heeseog KangDepartments of Orthopaedics and Cell Biology, Yale University School of Medicine, New Haven, CT 06510, USA.
Audrey Kerloc'hCentre for Complement and Inflammation Research (CCIR), Imperial College London, London W12 0NN, UK.
Maxime RotivalIntegrative Genomics and Medicine, MRC Clinical Sciences Centre, Imperial College London, London W12 0NN, UK.
Xiaoqing XuDepartments of Orthopaedics and Cell Biology, Yale University School of Medicine, New Haven, CT 06510, USA.
Qing ZhangDepartments of Orthopaedics and Cell Biology, Yale University School of Medicine, New Haven, CT 06510, USA.
Zelpha D'SouzaPhysiological Genomics and Medicine, MRC Clinical Sciences Centre, Imperial College London, London W12 0NN, UK.
Michael KimDepartments of Orthopaedics and Cell Biology, Yale University School of Medicine, New Haven, CT 06510, USA.
Jodi Carlson ScholzSection of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
Jeong-Hun KoCentre for Complement and Inflammation Research (CCIR), Imperial College London, London W12 0NN, UK.
Prashant K SrivastavaIntegrative Genomics and Medicine, MRC Clinical Sciences Centre, Imperial College London, London W12 0NN, UK.
Jonathan R GenzenDepartment of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, UT 84108, USA.
Weiguo CuiBlood Center of Wisconsin, Milwaukee, WI 53213, USA.
Timothy J AitmanPhysiological Genomics and Medicine, MRC Clinical Sciences Centre, Imperial College London, London W12 0NN, UK.
Laurence GameGenomics Laboratory, MRC Clinical Sciences Centre, Imperial College London, London W12 0NN, London, UK.
James E MelvinNational Institute of Dental and Craniofacial Research (NIDCR), National Institute of Health, Bethesda, MD 20892, USA.
Adedayo HaniduDepartment of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA.
Janice DimockDepartment of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA.
Jie ZhengDepartment of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA.
Donald SouzaDepartment of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA.
Aruna K BeheraDepartment of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA.
Gerald NaboznyDepartment of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA.
H Terence CookCentre for Complement and Inflammation Research (CCIR), Imperial College London, London W12 0NN, UK.
J H Duncan BassettMolecular Endocrinology Group, Department of Medicine, Imperial College London, London W12 0NN, UK.
Graham R WilliamsMolecular Endocrinology Group, Department of Medicine, Imperial College London, London W12 0NN, UK.
Jun LiDepartment of Immunology and Inflammation, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA.
Agnès VigneryDepartments of Orthopaedics and Cell Biology, Yale University School of Medicine, New Haven, CT 06510, USA. Electronic address: agnes.vignery@yale.edu.
Enrico PetrettoIntegrative Genomics and Medicine, MRC Clinical Sciences Centre, Imperial College London, London W12 0NN, UK. Electronic address: enrico.petretto@imperial.ac.uk.
Jacques BehmoarasCentre for Complement and Inflammation Research (CCIR), Imperial College London, London W12 0NN, UK. Electronic address: jacquesb@imperial.ac.uk.
Imperial College London · GBBoehringer Ingelheim (United States) · USYale University · USCentre for Inflammation Research · GBARUP Laboratories (United States) · USNational Institute of Dental and Craniofacial Research · USVersiti Blood Center of Wisconsin · US

Funding

NIDCR DIR Clinical TrainingZIEDE000727 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI MAYS, JACQUELINE · 2009 to 2025
$6.8M
Medical Research Council MC_U120061454Medical Research Council MC_U120097112Medical Research Council MR/M004716/1Wellcome Trust WT092523MA
6 · The paper itself

Abstract

Macrophages can fuse to form osteoclasts in bone or multinucleate giant cells (MGCs) as part of the immune response. We use a systems genetics approach in rat macrophages to unravel their genetic determinants of multinucleation and investigate their role in both bone homeostasis and inflammatory disease. We identify a trans-regulated gene network associated with macrophage multinucleation and Kcnn4 as being the most significantly trans-regulated gene in the network and induced at the onset of fusion. Kcnn4 is required for osteoclast and MGC formation in rodents and humans. Genetic deletion of Kcnn4 reduces macrophage multinucleation through modulation of Ca(2+) signaling, increases bone mass, and improves clinical outcome in arthritis. Pharmacological blockade of Kcnn4 reduces experimental glomerulonephritis. Our data implicate Kcnn4 in macrophage multinucleation, identifying it as a potential therapeutic target for inhibition of bone resorption and chronic inflammation.

Indexed as

AnimalsArthritisBone and BonesBone ResorptionCalcium SignalingCell NucleusCells, CulturedGene Regulatory NetworksGlomerulonephritisHomeostasisHumansIntermediate-Conductance Calcium-Activated Potassium ChannelsMacrophagesMice, KnockoutRats, Inbred LewRats, Inbred WKYIntermediate-Conductance Calcium-Activated Potassium ChannelsKcnn4 protein, ratReceptors, Immunologic

Identifiers

PMID25131209
PMCPMC4471813
OpenAlexW2094794221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.